The test can be done at home and only requires a pen and paper to complete, and something to keep track of your time limit.

It’s a groundbreaking step forward, but these scans are also showing that the disease develops differently in Black patients.

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study ...